We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00234689
First Posted: October 7, 2005
Last Update Posted: January 30, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Sheba Medical Center
October 6, 2005
October 7, 2005
January 30, 2008
January 2002
December 2004   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00234689 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients
Not Provided
Assessing the efficacy of Naltrexone as augmentation to SSRI in patients with OCD
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double
Obsessive Compulsive Disorder
Drug: Naltrexone
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
December 2004
December 2004   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosis of OCD
  • Treatment with SSRI for at least 10 weeks with no response

Exclusion Criteria:

  • Suffering from any medical condition
  • treatment with opiates
  • chronic use of drugs
  • Hepatitis or other liver related diseases
  • Incapability to sign an informed consent
Sexes Eligible for Study: All
18 Years to 65 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
Israel
 
 
NCT00234689
SHEBA-99-1897-JZ-CTIL
Not Provided
Not Provided
Not Provided
Prof. Joseph Zohar, Chaim Sheba Medical Center
Sheba Medical Center
Not Provided
Principal Investigator: Joseph Zohar, MD Tel Aviv University
Study Chair: Revital Amiaz, MD Tel Aviv University
Sheba Medical Center
January 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP